Resistent gegen Coronamassnahmen: Obwalden schliesst Gastrobetrieb nau.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nau.ch Daily Mail and Mail on Sunday newspapers.
Veru Announces Nature Medicine Publication Demonstrating that Enobosarm, an Androgen Receptor Targeted Agent, Inhibits Hormone Receptor Positive Metastatic Breast Cancer that has Become Resistant to Estrogen Receptor Targeted Endocrine and CDK4/6 Inhibitor Therapies
January 19, 2021 08:30 ET | Source: Veru Inc. Veru Inc. Miami, Florida, UNITED STATES International Study Establishes the Role of Androgen Receptor as a Tumor Suppressor in ER+ Advanced Breast Cancer Preclinical Studies Support Enobosarm’s Novel Mechanism of Action as an AR Activating Agent as a Potential Therapy in Patients with ER+ Metastatic Breast Cancer that have Become Resistant to Current Standard of Care Treatments Veru Also Announces that the Enobosarm Phase 3 Registration ARTEST Study is on Track to Commence Next Quarter in Patients with Metastatic ER+ Breast Cancer that is Resistant to Estrogen Receptor Targeted Endocrine Therapy and CDK4/6 Inhibit